SZYJ Medical Device Technology Group is a world leading medical device manufacturer of percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) surgical intervention devices.
SZYJ has successfully created more than 40 approved products, and its diversified product portfolio comprehensively covers all surgical treatment processes of PCI and PTA.
These include 25 products approved by Japan's PMDA, 22 products with the EU CE mark, 14 products approved by the US FDA and 15 products approved by the State Food and Drug Administration.
In the PCI balloon market, SZYJ's market share in Japan is 20%, ranking second; Europe's share is 11%, ranking fourth; The US market and China market share were 3% and 8% respectively, ranking sixth.
In the PTA balloon market, the company's market share in Japan is 13%, ranking third; The share of the United States is 12%, ranking fourth.
There are three main methods to treat coronary artery disease/peripheral artery disease:
1、 Drug therapy;
2、 Interventional therapy, including PCI for coronary artery disease and PTA for peripheral artery disease;
3、 Invasive surgical treatment. Due to the low risk and cost of PCI/PTA surgery, it has a similar treatment success rate with surgical treatment, so it is usually the first choice for the treatment of coronary artery disease/peripheral artery disease.
SZYJ's commercial products have won many "first" titles, such as the world's first 1.75mm scored balloon and the world's smallest non compliant scored balloon;
The world's first 1.0mm CTO balloon approved by FDA;
The world's first and only FDA approved non compliant PTA balloon compatible with all wire guide systems in the United States
The company has more than 100 authorized patents in major jurisdictions around the world, including 32 in the United States and 45 in China.
SZYJ's production bases are located in China and the Netherlands. As of the first half of this year, the company's production bases in China and the Netherlands had a total annual production capacity of about 1.5 million balloon products.